Oxford Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-40,000	Closed	-$650K	–	447
2024 Q2	$650K	Sell	40,000 -24,000	-38%	-$370K	0.63%	38
2024 Q1	$903K	Buy	+64,000	New	+$807K	0.94%	16
2020 Q1	$106K	Sell	11,829 -455,267	-97%	-$4.66M	0.01%	141
2019 Q4	$4.58M	Sell	467,096 -280,537	-38%	-$2.5M	0.13%	174
2019 Q3	$5.14M	Buy	+747,633	New	+$5.73M	0.12%	195
2019 Q1	–	Sell	-185,841	Closed	-$2.87M	–	1967
2018 Q4	$2.87M	Sell	185,841 -81,912	-31%	-$1.68M	0.07%	311
2018 Q3	$5.75M	Buy	267,753 +88,636	+49%	+$2.06M	0.12%	190
2018 Q2	$4.41M	Sell	179,117 -107,078	-37%	-$2.18M	0.08%	253
2018 Q1	$4.89M	Buy	+286,195	New	+$5.59M	0.1%	198
2016 Q4	–	Sell	-224,434	Closed	-$10.3M	–	863
2016 Q3	$10.3M	Buy	224,434 +123,986	+123%	+$6.47M	0.32%	66
2016 Q2	$5.05M	Sell	100,448 -28,720	-22%	-$1.53M	0.17%	147
2016 Q1	$6.91M	Sell	129,168 -42,003	-25%	-$2.46M	0.2%	113
2015 Q4	$11.3M	Buy	171,171 +132,187	+339%	+$8.17M	0.27%	65
2015 Q3	$2.2M	Buy	38,984 +29,511	+312%	+$1.91M	0.07%	272
2015 Q2	$560K	Sell	9,473 -20,543	-68%	-$1.27M	0.02%	514
2015 Q1	$1.87M	Sell	30,016 -30,134	-50%	-$1.75M	0.05%	376
2014 Q4	$3.43M	Buy	+60,150	New	+$3.35M	0.08%	262
2014 Q3	–	Sell	-94,567	Closed	-$4.96M	–	755
2014 Q2	$4.96M	Buy	+94,567	New	+$4.83M	0.16%	167
2014 Q1	–	Sell	-241,115	Closed	-$9.66M	–	765
2013 Q4	$9.66M	Buy	+241,115	New	+$9.49M	0.24%	107
2013 Q3	–	Sell	-229,360	Closed	-$8.99M	–	895
2013 Q2	$8.99M	Buy	+229,360	New	+$8.93M	0.24%	102